|Articles|September 13, 2010

Hatch-Waxman Act

In 1984, the Hatch-Waxman Act is signed into law. Its full effects were not felt until the wave of patent expirations started after it took effect and has changed the economics of the pharmaceutical industry.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

Addressing Preclinical Gaps to Prevent Biotech Trial Delays

ByBen Edwards,Andy Studna, Senior Editor

October 15th 2025

Reframing the IND: From Tactical Requirement to Strategic Opportunity

ByMichael F Murphy, MD, PhD

October 15th 2025

Enhancing Data Quality and Real-World Evidence in Clinical Research

ByAndy Studna, Senior Editor

October 14th 2025

Answering the Sustainability Call: Digital Health Technologies and eCOA

ByEstelle Haenel, PharmD, PhD,Farrell Healion,Scottie Kern

October 14th 2025

Are Clinical Trial Diversity Initiatives at Risk of Being Dismantled?

ByRebecca Johnson, PhD

October 14th 2025

Trending on Applied Clinical Trials Online

Are Clinical Trial Diversity Initiatives at Risk of Being Dismantled?

Answering the Sustainability Call: Digital Health Technologies and eCOA

KRI Overload: When More Isn’t Better

Applied Clinical Trials' 2025 State of the Industry Survey

Enhancing Data Quality and Real-World Evidence in Clinical Research

© 2025 MJH Life Sciences^®

All rights reserved.